Savant Capital, LLC Infinity Pharmaceuticals, Inc. Call Options Transaction History
Savant Capital, LLC
- $11.7 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding INFI
# of Institutions
3Shares Held
1.26MCall Options Held
0Put Options Held
0About INFINITY PHARMACEUTICALS, INC.
- Ticker INFI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 89,277,904
- Description
- Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...